PowerUp Acquisition Corp. (PWUP)

NASDAQ: PWUP · IEX Real-Time Price · USD
12.00
0.00 (0.00%)
May 17, 2024, 4:30 PM EDT - Market closed
Market Cap 107.89M
Revenue (ttm) n/a
Net Income (ttm) 6.30M
Shares Out 8.99M
EPS (ttm) 0.18
PE Ratio 66.67
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,464
Open 12.62
Previous Close 12.00
Day's Range 11.17 - 12.62
52-Week Range 10.07 - 13.23
Beta -0.01
Analysts n/a
Price Target n/a
Earnings Date n/a

About PWUP

PowerUp Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on video gaming, gaming adjacent, and metaverse businesses. PowerUp Acquisition Corp. was incorporated in 2021 and is based in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Feb 18, 2022
Country United States
Stock Exchange NASDAQ
Ticker Symbol PWUP
Full Company Profile

Financial Performance

Financial Statements

News

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

New York, NY, May 16, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that its extraordinary general meeting of shareholders (the “Meeting”), which wa...

2 days ago - GlobeNewsWire

PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination

Tarrytown, NY and New York, NY, Jan. 29, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (“PowerUp”) (Nasdaq: PWUP) and Visiox Pharmaceuticals, Inc. (“Visiox”), a commercial-stage biopharmaceutical...

3 months ago - GlobeNewsWire

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Tarrytown, NY and New York, NY, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Visiox Pharmaceuticals, Inc. (“Visiox” or the “Company”), a commercial-stage biopharmaceutical company, and PowerUp Acquisition Corp. ...

5 months ago - GlobeNewsWire

PowerUp Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 11, 2022

NEW YORK--(BUSINESS WIRE)--PowerUp Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 11, 2022

2 years ago - Business Wire